You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
8 April 2026 - Solvonis Therapeutics plc (LSE: SVNS), a biopharmaceutical company developing small-molecule treatments for central nervous system disorders, announced on Wednesday that it has been granted a second US patent (No. 12,595,269) covering ...
8 April 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) revealed on Wednesday that it has received approval from China's National Medical Products Administration for Exdensur (depemokimab) as an add-on treatment for adults with c...
8 April 2026 - AI-powered, integrated digital health company MedPal AI plc (AIM: MPAL) (FRA: Z1N) declared on Wednesday that it has launched its MedPal Health Operating System, a vertically integrated digital health platform designed to deliver perso...
8 April 2026 - Oncology company Coiled Therapeutics plc (AIM: COIL) reported on Monday that it has recorded improved clinical outcomes from its ongoing Phase I/II trial (NCT06136884) of AO-252, supporting a strategic shift towards targeted dose expan...
8 April 2026 - Clinical research site network CenExel Clinical Research announced on Tuesday the appointment of Dr. Sy Pretorius as chief executive officer, effective 1 May 2026.Dr. Pretorius succeeds Ryan Brooks, who will remain a member of the comp...
8 April 2026 - IDEOlogy Health, a provider of non-promotional, multi-channel medical education to oncology professionals, on Tuesday announced two exclusive strategic partnership agreements with West Cancer Center & Research Institute, designed t...
8 April 2026 - India-based global pharmaceutical company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Tuesday that it has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application for Dapaglifloz...